Total Funding
16
20
Total FundingSeries F raised
Growth Score
-3 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
186056
Atox Bio is a biotechnology company that specializes in infectious diseases, immunomodulators, and critical care.
Gila Arad: Scientific consult, Founder
Raymond Kaempfer: Scientific FounderPast Role: Harvard University, Biology Faculty
Yissum Technology Transfer Company of the Hebrew University
About the Company
Atox Bio is a biotechnology company that specializes in infectious diseases, immunomodulators, and critical care.It focuses on novel modulators of the immune response that target key multiple and interrelated pathways of both the adaptive and innate immune response that play critical roles in infectious and inflammatory diseases as well as
ischemia/reperfusion injuries.
The company was founded in 2003 and headquartered in HaMerkaz, Israel.
